Abbott Laboratories will acquire Cardiovascular Systems in deal worth $890 million
February 09, 2023 at 08:12 AM EST
The deal for New Brighton-based Cardiovascular Systems is expected to improve Abbott's portfolio of devices that treat vascular disease.
